Blood Group Genotyping for Sickle Cell and Thalassaemi

A Contract Award Notice
by NHS ENGLAND, LEEDS

Source
Contracts Finder
Type
Contract (Services)
Duration
10.5 month
Value
£141K
Sector
HEALTH
Published
03 Sep 2025
Delivery
12 May 2025 to 31 Mar 2026
Deadline
05 May 2025 11:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Award Detail

1 NHS Blood & Transplant NHSBT (Bristol)
  • Value: £140,671

CPV Codes

  • 85111810 - Blood analysis services

Indicators

  • Contract is suitable for SMEs.
  • Contract is suitable for VCOs.

Reference

Domains